HeyJaredNeuroethics Today
It's time for Neuroethics to make today’s news. Katherine Bassil, an upcoming neuroscientist and neuroethics enthusiast, has always tried to advocate for bridging the fields of neuroscience and neuroethics together.
- Indexed episodes, last 90 days
- 3
- Latest publication
- Sep 15, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 21, 2026
Latest episodes
I Joined a Psychedelics Clinical Trial: Now What? - Edward Jacobs (opens the original)
Read excerpt
In the fourth episode of Season 5 on the Neuroethics of Psychedelics, we speak with Dr. Edward Jacobs about post-trial access to psychedelics among certain patients. Dr. Jacobs is currently a postdoctoral research fellow at Johns Hopkins’ Center for Psychedelic and Consciousness Research and the Associate Director of HOPE – The Hub at Oxford for Psychedelic Ethics . He is also a contributing writer to ‘The Ethics Corner’ at The Psychedelic Practitioner . In this episode, Dr. Jacobs discusses the
Can You Really Consent to Psychedelics Research? - Daniel Villiger (opens the original)
Read excerpt
In the third episode of Season 5 on the Neuroethics of Psychedelics, we speak with Dr. Daniel Villiger about consenting to psychedelic research. Dr. Villiger is a philosopher and postdoctoral fellow at the Institute of Philosophy at the University of Zurich in Switzerland and the author of the article " Giving Consent to the Ineffable " in the Neuroethics Journal on informed consent and psychedelics research. In this episode, Dr. Villiger highlights the challenges with informed consent during ps
Buyer beware: the limitations of psychedelics research - Eiko Fried (opens the original)
Read excerpt
In the second episode of Season 5 on the Neuroethics of Psychedelics, we speak with Eiko Fried about psychedelic research, the facts, the myths, and the hype. Professor Fried is a professor of Mental Health & Data Science at Leiden University. He is the co-Founder of the local Open Science Community, and a previous member of the Young Academy Leiden. In this episode, we discuss the limitations of existing psychedelics research, the implications of exaggerated claims, and the role of hype in movi
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.